261 related articles for article (PubMed ID: 9338723)
21. Influence of environmental temperature on incidence of indinavir-related nephrolithiasis.
Martínez E; Leguizamón M; Mallolas J; Miró JM; Gatell JM
Clin Infect Dis; 1999 Aug; 29(2):422-5. PubMed ID: 10476752
[TBL] [Abstract][Full Text] [Related]
22. Urolithiasis and the protease inhibitor indinavir.
Hermieu J; Prévot M; Ravery V; Sauty L; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
Eur Urol; 1999; 35(3):239-41. PubMed ID: 10072627
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index.
Meraviglia P; Angeli E; Del Sorbo F; Rombolà G; Viganò P; Orlando G; Cordier L; Faggion I; Cargnel A
AIDS; 2002 Oct; 16(15):2089-93. PubMed ID: 12370513
[TBL] [Abstract][Full Text] [Related]
24. [Crystalluria and nephrolithiasis during therapy with the protease inhibitor indinavir].
Rickerts V; Kober A; Stille W
Dtsch Med Wochenschr; 1997 Jun; 122(24):803. PubMed ID: 9229567
[No Abstract] [Full Text] [Related]
25. Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy.
Blake SP; McNicholas MM; Raptopoulos V
AJR Am J Roentgenol; 1998 Sep; 171(3):717-20. PubMed ID: 9725303
[TBL] [Abstract][Full Text] [Related]
26. The choice of HIV protease inhibitor: indinavir is currently the best option.
Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067
[TBL] [Abstract][Full Text] [Related]
27. [Anuria in HIV+ patients treated with indinavir].
Rebassa Llull MJ; Conte Visús A; Grases Freixedas F; Muñoz Vélez D; Mus Malleu A; Torrens Darder I; Sanz-Gadea CG; Ozonas Moragues M
Arch Esp Urol; 2000 Oct; 53(8):719-21. PubMed ID: 11126974
[TBL] [Abstract][Full Text] [Related]
28. Symptomatic crystalluria associated with indinavir.
Famularo G; Di Toro S; Moretti S; De Simone C
Ann Pharmacother; 2000 Dec; 34(12):1414-8. PubMed ID: 11144699
[TBL] [Abstract][Full Text] [Related]
29. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria.
Perazella MA; Kashgarian M; Cooney E
Clin Nephrol; 1998 Sep; 50(3):194-6. PubMed ID: 9776425
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous side effects induced by indinavir.
Calista D; Boschini A
Eur J Dermatol; 2000 Jun; 10(4):292-6. PubMed ID: 10846257
[TBL] [Abstract][Full Text] [Related]
31. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir.
Gagnon RF; Tecimer SN; Watters AK; Tsoukas CM
Am J Kidney Dis; 2000 Sep; 36(3):507-15. PubMed ID: 10977782
[TBL] [Abstract][Full Text] [Related]
32. Effects of escin on indinavir crystallization time in the urine of patients with HIV-I infection: a multicenter, randomized, open-label, controlled, four-period crossover trial.
Grases F; García-González R; Redondo E; Costa-Bauzá A; Simonet BM; Sartini RP; Bassa A; Gallegos C; Payeras A; Saro D; Martinez AI; Cifuentes C; Homar F; Murillo JA; Fernández C; Riera M; Conte A
Clin Ther; 2004 Dec; 26(12):2045-55. PubMed ID: 15823768
[TBL] [Abstract][Full Text] [Related]
33. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
Manfredi R; Chiodo F
J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
[TBL] [Abstract][Full Text] [Related]
34. Ureteral obstruction secondary to indinavir in the pediatric HIV population.
Noble CB; Klein LT; Staiman VR; Neu N; Hensle TW; Berdon WE
Pediatr Radiol; 1998 Aug; 28(8):627-9. PubMed ID: 9716639
[TBL] [Abstract][Full Text] [Related]
35. Indinavir-induced nephropathy.
Grabe DW; Eisele G; Miller C; Singh J; Stein D
Clin Nephrol; 1999 Mar; 51(3):181-3. PubMed ID: 10099891
[TBL] [Abstract][Full Text] [Related]
36. Adhesive capsulitis of shoulder and treatment with protease inhibitors in patients with human immunodeficiency virus infection: report of 8 cases.
Grasland A; Ziza JM; Raguin G; Pouchot J; Vinceneux P
J Rheumatol; 2000 Nov; 27(11):2642-6. PubMed ID: 11093447
[TBL] [Abstract][Full Text] [Related]
37. [Nephritic colic due to indinavir].
Hermieu JF; Prévot MH; Ravery V; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
Presse Med; 1998 Mar; 27(10):465-7. PubMed ID: 9767973
[TBL] [Abstract][Full Text] [Related]
38. [Indinavir urolithiasis in HIV-positive patients. Treatment and prophylaxis].
Kalaitzis C; Touloupidis S; Patris E; Lehrich K; Kuntz RM
Urologe A; 2004 Feb; 43(2):168-71. PubMed ID: 14991118
[TBL] [Abstract][Full Text] [Related]
39. Indinavir urinary stones as origin of upper urinary tract obstruction.
John H; Müller NJ; Opravil M; Hauri D
Urol Int; 1997; 59(4):257-9. PubMed ID: 9444746
[TBL] [Abstract][Full Text] [Related]
40. Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases.
Berns JS; Cohen RM; Silverman M; Turner J
Am J Kidney Dis; 1997 Oct; 30(4):558-60. PubMed ID: 9328372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
